 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
1 to 8 of 8 results |
|
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
Bacskai B. on PAPER: van Assema DM. et al., 2012, Recommendation Only. 5 Dec 2011.
|
 |
 |
 |
 |
 |
Bacskai B, Hyman B. on NEWS: Seeing Is Believing—Plaque Growth Is Slow, Tapers With Age, Several papers now have used multiphoton imaging to monitor plaques over time in AD transgenic... 6 Feb 2011.
|
 |
 |
 |
 |
 |
Bacskai B. on PAPER: Lee S. et al., 2010, Recommendation Only. 3 Oct 2010.
|
 |
 |
 |
 |
 |
Bacskai B. on PAPER: Reinke AA. et al., 2010, Recommendation Only. 9 Aug 2010.
|
 |
 |
 |
 |
 |
Bacskai B. on PAPER: Lebson L. et al., 2010, Recommendation Only. 7 Aug 2010.
|
 |
 |
 |
 |
 |
Bacskai B. on PAPER: Fuhrmann M. et al., 2010, This paper by Fuhrmann et al. shows elegant two-photon imaging of neurons and microglia in the... 29 Mar 2010.
|
 |
 |
 |
 |
 |
Bacskai B. on NEWS: Hyperactive Neurons and Amyloid, Side by Side, This is a great paper that confirms our and others’ work that senile plaques are a focal source... 22 Sep 2008.
|
 |
 |
 |
 |
 |
Bacskai B. on NEWS: Busting up Plaques—Small Molecules Aided by Protein Heavies, This is an interesting paper that describes a clever approach for targeting amyloid-β and... 8 Nov 2004.
|
 |
 |
 |
 |
 |
 |
1 to 8 of 8 results |
|
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Should the FDA be allowed to use data from overseas clinical trials? |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Absolutely, we are running out of viable subjects in the U.S. |
 |
 |
 |
 |
 |
 |
9 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Yes, so long as the data is reliable |
 |
 |
 |
 |
 |
 |
31 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the trials are not as rigorous |
 |
 |
 |
 |
 |
 |
3 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the data should be repeated in the U.S. |
 |
 |
 |
 |
 |
 |
5 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the drug sponsors are just trying to cut corners |
 |
 |
 |
 |
 |
 |
3 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Responses: 51 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
|
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Archived Polls |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |

|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |